Founders Financial Securities LLC Abb Vie Inc. Transaction History

Founders Financial Securities LLC

$1.06 Billion
Q3 2024

A detailed history of Founders Financial Securities LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Founders Financial Securities LLC holds 4,438 shares of ABBV stock, worth $779,224. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,438

Previous 6,163 27.99%

Holding current value

$779,224

Previous $1.06 Million 17.12%

% of portfolio

0.08%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $282,624 - $343,844	-1,725 Reduced 27.99%	4,438 $876,000
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $247,509 - $289,035	1,599 Added 35.04%	6,163 $1.06 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $49,064 - $55,904	-307 Reduced 6.3%	4,564 $831,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $117,372 - $132,189	853 Added 21.23%	4,871 $754,000
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $48,359 - $55,983	362 Added 9.9%	4,018 $598,000
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $32,729 - $40,730	247 Added 7.25%	3,656 $492,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $18,943 - $21,816	-131 Reduced 3.7%	3,409 $543,000
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $49,376 - $59,215	-357 Reduced 9.16%	3,540 $572,000
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $43,484 - $49,873	324 Added 9.07%	3,897 $523,000
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $3,715 - $4,723	-27 Reduced 0.75%	3,573 $547,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $7,786 - $9,661	59 Added 1.67%	3,600 $584,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $5,801 - $7,340	-54 Reduced 1.5%	3,541 $479,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $18,194 - $20,653	171 Added 4.99%	3,595 $388,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $5,786 - $6,446	55 Added 1.63%	3,424 $386,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $73,553 - $80,973	-719 Reduced 17.59%	3,369 $365,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $131,601 - $177,675	1,635 Added 66.65%	4,088 $438,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $222,936 - $261,653	-2,595 Reduced 51.41%	2,453 $215,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $370,371 - $495,612	5,048 New	5,048 $490,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.

Account

Founders Financial Securities LLC Abb Vie Inc. Transaction History